Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such liraglutide-induced improvement i...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Fujishima Yuya, Maeda Norikazu, Inoue Kana, Kashine Susumu, Nishizawa Hitoshi, Hirata Ayumu, Kozawa Junji, Yasuda Tetsuyuki, Okita Kohei, Imagawa Akihisa, Funahashi Tohru, Shimomura Iichiro
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2012-09-01
Ráidu:	Cardiovascular Diabetology
Fáttát:	Liraglutide Glucagon-like peptide-1 (GLP-1) Obesity Eating behavior Diabetes Incretin
Liŋkkat:	http://www.cardiab.com/content/11/1/107
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!